---
created: 2025-04-13
updated: 2025-04-13T10:53
id: tK%m+Vy_l_
specialty: pharmaco
specialty_id: 497
tags:
  - source/ak-original-decks::step-1::lolnotacop::drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies::trastuzumab
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::26-trastuzumab
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::03-kinase-inhibitors-&-monoclonal-antibodies::02-rituximab,-cetuximab,-bevacizumab,-alemtuzumab,-trastuzumab
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::2000-2999::2093"
type: flashcard
---

# Question
HER2 (c-erbB2) is a(n) **epidermal growth factor** receptor found in certain types of **breast** and gallbladder carcinoma

---

# Answer
growth factor receptor, thus has intrinsic tyrosine kinase activity, ACCELERATING CELL PROLIFERATION